Activated cytotoxic T lymphocytes and natural killer cells, which are involved in the pathogenesis of GVHD and viral infections after SCT produce granzymes (Grs). This study performed an ELISA in the serum of 86 patients at various time points before and after Allo-SCT to investigate GrA and GrB levels as potential markers for these serious complications. The increase in Gr levels from the day of transplantation until the appearance of the complication was highly predictive. If GrA increased to three times its pretransplant level, the cumulative incidence of developing acute GVHD was 73% and for CMV infection 68%, in comparison with 45 and 35%, respectively, for patients without these complications. A strong increase in GrA level correlated with clinical severity of acute GVHD. No correlation was observed with early relapse or long-term overall survival. In addition to clinical parameters, a strong increase in GrA levels was identified as an independent marker for the occurrence of acute GVHD as well as for CMV infection. Similar effects were observed with GrB. In conclusion, Gr protein levels can also be used as a marker for complications after Allo-SCT.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Pipkin ME, Lieberman J . Delivering the kiss of death: progress on understanding how perforin works. Curr Opin Immunol 2007; 19: 301–308.
Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J . Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal graft-versus-host disease. Blood 1996; 183: 657–661.
Baker MB, Altman NH, Podack ER, Levy RB . The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med 1996; 183: 2645–2656.
Schmaltz C, Alpdogan O, Horndasch KJ, Muriglan SJ, Kappel BJ, Teshima T et al. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 2001; 97: 2886–2895.
Graubert TA, Russell JH, Ley TJ . The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 1996; 87: 1232–1237.
Graubert TA, DiPersio JF, Russell JH, Ley TJ . Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J Clin Invest 1997; 100: 904–911.
Takata M . Immunohistochemical identification of perforin-positive cytotoxic lymphocytes in graft-versus-host disease. Am J Clin Pathol 1995; 103: 324–329.
Higaki Y, Yamada O, Okamura T, Mizoguchi H, Kawashima M . Granzyme-B-containing lymphocyte involvement in epidermal injury in graft-versus-host disease. Dermatology 2001; 202: 94–98.
Jaksch M, Uzunel M, Martinez Cangana G, Remberger M, Mattsson J . Increased levels of immune transcript in patients with acute GvHD after allogeneic stem cell transplantation. Bone Marrow Transplant 2003; 31: 183–190.
Jaksch M, Remberger M, Mattsson J . Increased immune transcript levels are correlated with acute graft-versus-host disease and cytomegalovirus response after allogeneic stem cell transplantation. Transplantation 2004; 77: 195–200.
Kircher B, Hack CE, Dickinson AM, Wang XN, Oudshoorn M, Sachs A et al. Towards functional transplant donor matching by measurement of granzyme A and granzyme B production levels. J Immunol Methods 2004; 293: 51–59.
Nachbaur D, Eibl B, Kropshofer G, Meister B, Mitterschiffthaler A, Schennach H et al. In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation. J Hematother Stem Cell Res 2002; 11: 731–737.
Kaplan EL, Meier P . Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
Spaeny-Dekking EHA, Hanna WL, Wolbink AM, Wever PC, Kummer AJ, Swaak AJG et al. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J Immunol 1998; 160: 3610–3616.
Clément MV, Haddad P, Soulié A, Benvenuti C, Lichtenheld MG, Podack ER et al. Perforin and granzyme B as markers for acute rejection in heart transplantation. Int Immunol 1991; 3: 1175–1181.
Griffiths GM, Namikawa R, Mueller C, Liu C-C, Young J D-E, Billingham M et al. Granzyme A and perforin as markers for rejection in cardiac transplantation. Eur J Immunol 1991; 21: 687–693.
Cashion AK, Sabek OM, Driscoll CJ, Gaber LW, Gaber AO . Serial peripheral blood cytotoxic lymphocyte gene expression measurements for prediction of pancreas transplant rejection. Transplant Proc 2006; 38: 3676–3677.
Kummer JA, Wever PC, Kamp AM, ten Berge IJ, Hack CE, Weening JJ . Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. Kidney Int 1995; 47: 70–77.
Veale JL, Liang LW, Zhang Q, Gjertson DW, Du Z, Bloomquist EW et al. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol 2006; 67: 7777–7786.
Strehlau J, Pavlakis M, Lipman M, Maslinski W, Shapiro M, Strom TB . The intragraft gene activation of markers reflecting T-cell-activation and –cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin Nephrol 1996; 46: 30–33.
Inkinen K, Lahesmaa R, Brandt A, Katajamaa M, Halme L, Hockerstedt K et al. DNA microarray-based gene expression profiles of cytomegalovirus infection and acute rejection in liver transplants. Transplant Proc 2005; 37: 1227–1229.
Clément MV, Legros-Maïda S, Israël-Biet D, Carnot F, Soulié A, Reynaud P et al. Perforin and granzyme B expression is associated with severe acute rejection. Evidence for in situ localization in alveolar lymphocytes of lung-transplanted patients. Transplantation 1994; 57: 322–326.
Bittmann I, Müller C, Behr J, Groetzner J, Frey L, Löhrs U . Fas/FasL and perforin/granzyme pathway in acute rejection and diffuse alveolar damage after allogeneic lung transplantation-a human biopsy study. Virchows Arch 2004; 445: 375–381.
Han D, Xu X, Baidal D, Leith J, Ricordi C, Alejandro R et al. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection. Diabetes 2004; 53: 2281–2290.
Altimari A, Gruppioni E, Capizzi E, Bagni A, Corti B, Fiorentino M et al. Blood monitoring of granzyme B and perforin expression after intestinal transplantation: Considerations on clinical relevance. Transplantation 2008; 85: 1778–1783.
ten Berge IJ, Wever PC, Wolbink AM, Surachno J, Wertheim PM, Spaeny LH et al. Increased systemic levels of soluble granzymes A and B during primary cytomegalovirus infection after renal transplantation. Transplant Proc 1998; 30: 3972–3974.
Wever PC, Spaeny LH, van der Vliet HJ, Rentenaar RJ, Wolbink AM, Surachno J et al. Expression of granzyme B during primary cytomegalovirus infection after renal transplantation. J Infect Dis 1999; 179: 693–696.
Rowshani AT, Strik MC, Molenaar R, Yong SL, Wolbink AM, Bemelman FJ et al. The granzyme B inhibitor SERPINB9 (proteinase inhibitor 9) circulates in blood and increases on primary cytomegalovirus infection after renal transplantation. J Infect Dis 2005; 192: 1908–1911.
Pan L, Teshima T, Hill GR, Bungard D, Brinson YS, Reddy VS et al. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood 1999; 93: 4071–4078.
Tsukada N, Kobata T, Aizawa Y, Yagita H, Okumura K . Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation. Blood 1999; 93: 2738–2747.
Hsieh MH, Korngold R . Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses. Blood 2000; 96: 1047–1055.
About this article
Cite this article
Kircher, B., Schumacher, P. & Nachbaur, D. Granzymes A and B serum levels in allo-SCT. Bone Marrow Transplant 43, 787–791 (2009). https://doi.org/10.1038/bmt.2008.395
- CMV infection
This article is cited by
Bone Marrow Transplantation (2013)